Tech Stock News
Monday, March 27, 2023
Dare Bioscience Inc (NASDAQ: DARE) arrived into a Cooperative Research and Development Agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development for the essential Stage 3 study of Ovaprene®. Ovaprene® is a trial hormone-free regular intravaginal contraceptive presently in scientific development for the deterrence of the prenatal […]
Dare Bioscience Inc (NASDAQ: DARE) stock now trades at $1.83 (down 2.76%). It jumped to $2.26 after Bill & Gates foundation decided to grant up to $49 million. Dare Bioscience will use the grant for technology development and preclinical activities for advancing its Dare-Larc1, an investigational contraceptive, into human clinical […]
Dare Bioscience Inc soars after receiving Gates Foundation grant Dare Bioscience Inc (NASDAQ: DARE) has gained 50.38% since the beginning of this year. On Thursday, the stock exited at $2.00 after collecting 12 cents to go up 6.38%. Throughout the day, DARE was trading within the range of $1.71 – […]